Anúncio
Anúncio
TERN
Terns Pharmaceuticals, Inc. Common Stock
40.14
USDPatrocinado
-0.26
-0.65%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
40.27
+0.14
+0.35%
Relatórios de Lucros TERN
Rácio de surpresa positiva
TERN separação 16 de 20 últimas estimativas.
80%
Próximo Relatório
Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.29
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+7.41%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+20.83%
Terns Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, TERN reported earnings of -0.27 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 10.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an aumentar of 7.41% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Terns Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Terns Pharmaceuticals, Inc. Common Stock reported EPS of -$0.27, beating estimates by 10.68%, and revenue of $0.00, 0% as expectations.
How did the market react to Terns Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 7.64%, changed from $19.12 before the earnings release to $20.58 the day after.
When is Terns Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18 de mar. de 2026.
What are the forecasts for Terns Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 13
analistas, Terns Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio